SCHEMBL126893

SCHEMBL126893

CN(CC(=O)O)CP(=O)(O)O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MVD P53602 2/20 0.46
TDP1 Q9NUW8 3/20 0.40
LMNA P02545 2/20 0.40
TSHR P16473 2/20 0.40
BLM P54132 2/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
HPGD P15428 1/20 0.40
EYA2 O00167 1/20 0.35
APP P05067 1/20 0.35
ACE P12821 1/20 0.35
ALOX15 P16050 2/20 0.33
BHMT Q93088 1/20 0.33
USP2 O75604 1/20 0.33
KDM4E B2RXH2 1/20 0.33
CHRM2 P08172 1/20 0.33
ADRA2A P08913 1/20 0.33
DRD1 P21728 1/20 0.33
SLC6A2 P23975 1/20 0.33
SLC6A4 P31645 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3100743 0.79 USP2 (0.32) MVDMEN1KMT2AALOX15USP2
SCHEMBL384746 0.79 USP2 (0.42) MEN1KMT2AALOX15USP2KDM4E
SCHEMBL385005 0.77 MVD (0.51) MVDTDP1LMNATSHRBLM
SCHEMBL22061 0.76 TDP1 (0.47) MVDTDP1LMNATSHRBLM
SCHEMBL10482442 0.76 MMP2 (0.34) LMNAALOX15USP2S1PR2S1PR1
SCHEMBL67368 0.75 TDP1 (0.50) MVDTDP1LMNATSHRBLM
SCHEMBL65674 0.75 TDP1 (0.50) MVDTDP1LMNATSHRBLM
SCHEMBL27709276 0.75 TDP1 (0.50) MVDTDP1LMNATSHRBLM
SCHEMBL7167781 0.75 TDP1 (0.43) MVDTDP1LMNATSHRBLM
SCHEMBL11895837 0.75 TDP1 (0.50) MVDTDP1LMNATSHRBLM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 739 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12605695-B2 Molecularly imprinted fluorescent polymers for direct detection of glyphosate, its degradation products, and metabolites BUNDESREPUBLIK DEUTSCHLAND, VERTRETEN DURCH DEN BUNDESMINISTER FÜR WIRTSCHAFT UND ENERGIE, DIESER VERTRETEN DURCH DEN PRÄSIDENTEN DER BUNDESANSTALT FÜR MATERIALFORSCHUNG UND -PRÜFUNG, (BAM) (DE) 2026-04-21 US claimed
CN-118777255-B Glyphosate product based on near infrared spectrum and byproduct detection method thereof 镇江江南化工有限公司 2025-04-01 CN claimed
CN-118777255-A Glyphosate product based on near infrared spectrum and byproduct detection method thereof 镇江江南化工有限公司 2024-10-15 CN claimed
CN-114965840-B Method for detecting glyphosate, glufosinate and metabolites in biological fluid 公安部物证鉴定中心 2024-06-14 CN claimed
CN-117849209-A Method for rapidly determining N-methyl glyphosate content by liquid chromatography 湖北泰盛化工有限公司 2024-04-09 CN claimed
US-20240066500-A1 MOLECULARLY IMPRINTED FLUORESCENT POLYMERS FOR DIRECT DETECTION OF GLYPHOSATE, ITS DEGRADATION PRODUCTS, AND METABOLITES Bundesrepblik Deutschland, vertreten durch den Bundesminister für Wirtschaft und Energie, dieser ver (DE) 2024-02-29 US claimed
US-10905123-B2 Herbicidal compounds SYNGENTA PARTICIPATIONS AG (CH) 2021-02-02 US claimed
EP-3255989-B1 HERBICIDAL COMPOUNDS SYNGENTA PARTICIPATIONS AG (CH) 2020-09-16 EP claimed
US-20180027815-A1 HERBICIDAL COMPOUNDS SYNGENTA PARTICIPATIONS AG (CH) 2018-02-01 US claimed
EP-3255989-A1 HERBICIDAL COMPOUNDS Syngenta Participations AG (CH) 2017-12-20 EP claimed
JP-2004501161-A 2004-01-15 JP claimed
US-20030207797-A1 Glycopeptides that are substituted with one or more substituents each comprising one or more phosphono groups; and pharmaceutical compositions containing such glycopeptide derivatives. The disclosed glycopeptide derivatives are useful CUMBERLAND PHARMACEUTICALS INC. 2003-11-06 US claimed
US-6635618-B2 Glycopeptide phosphonate derivatives THERAVANCE, INC. 2003-10-21 US claimed
EP-1292612-A2 GLYCOPEPTIDE PHOSPHONATE DERIVATIVES Advanced Medicine, Inc. (US) 2003-03-19 EP claimed
US-20020197725-A1 Use of infrared spectroscopy for on-line process control and endpoint detection MONSANTO TECHNOLOGY LLC 2002-12-26 US claimed
WO-2002095373-A1 USE OF INFRARED SPECTROSCOPY FOR ON-LINE PROCESS CONTROL AND ENDPOINT DETECTION MONSANTO TECHNOLOGY LLC (US) 2002-11-28 WO claimed
US-20020022590-A1 Useful as antibiotics; reduced tissue accumulation and/or nephrotoxicity when administered to a mammal; useful against vancomycin-resistant microorganisms CUMBERLAND PHARMACEUTICALS INC. 2002-02-21 US claimed
WO-2001098328-A2 GLYCOPEPTIDE PHOSPHONATE DERIVATIVES THERAVANCE, INC. (US) 2001-12-27 WO claimed
US-4495363-A HERBICIDES-PHYTOTOXICANTS MONSANTO CO. (US) 1985-01-22 US claimed
US-3977860-A PHYTOTOXICANTS MONSANTO COMPANY (US) 1976-08-31 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12605695-B2 Molecularly imprinted fluorescent polymers for direct detection of glyphosate, its degradation products, and metabolites GRIN3A, PAM, GYPA MVD 496/4885TDP1 1850/4885LMNA 680/4885
US-20020022590-A1 Useful as antibiotics; reduced tissue accumulation and/or nephrotoxicity when administered to a mammal; useful against vancomycin-resistant microorganisms GLS, PIGS, PAG1 MVD 164/4885TDP1 2214/4885LMNA 3533/4885
US-20180027815-A1 HERBICIDAL COMPOUNDS DDT, HPD, PDXK MVD 257/4885TDP1 1762/4885LMNA 3743/4885
US-20030207797-A1 Glycopeptides that are substituted with one or more substituents each comprising one or more phosphono groups; and pharmaceutical compositions containing such glycopeptide derivatives. The disclosed glycopeptide derivatives are useful PAG1, PTMS, B3GAT3 MVD 357/4885TDP1 1276/4885LMNA 4250/4885
US-10905123-B2 Herbicidal compounds DDT, HPD, PDXK MVD 257/4885TDP1 1762/4885LMNA 3743/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.